Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the ...
BioNTech said on Thursday that its collaboration with Pfizer has not changed, when asked to comment on a report that Pfizer ...
Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...
A BioNTech spokesperson downplayed the news, insisting that the two companies remain “close” and have a “strong collaboration ...
Pfizer has sold a significant portion of its stake in German drugmaker BioNTech SE, a more than five years after the two ...
Pfizer sell 508M stake in BioNTech through an overnight block trade, marking its exit from the COVID-19 vaccine partner's equity.
BioNTech (NasdaqGS:BNTX) shares caught investors’ attention after Pfizer revealed plans to sell its remaining stake in the company through an overnight block trade. This announcement prompted a wave ...
Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...
Move marks shift after years of mRNA collaboration that produced COVID-19 vaccine.
[NEW YORK] Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech, a remnant from one of the ...
The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results